MC Sciences
PrivateLast Round
Series A
Apr 1, 2026
Total Funding Raised
$5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MC Sciences operates in Healthcare & Life Sciences and is based in Meckenheim. Its latest recorded funding round was a Series A round in April 2026.
MC Sciences is a biotechnology company that develops first-in-class therapeutics targeting mast cells to treat a variety of diseases including immunology, dermatology, respiratory, and gastrointestinal conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MC Sciences Comparables
Compare MC Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allegria Therapeutics AG | 81% | |
| Evommune | 78% | |
| Incyte Corporation | 78% |
For institutional investors. Book with your work email.
MC Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 1, 2026 | ||||
| Seed | Apr 15, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MC Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ROC Venture Group | Seed, Series A |
| Canaan Partners | Series A |
| LifeArc Ventures | Seed, Series A |
| Bayern Kapital | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Raised Series A with Bayern Kapital, LifeArc Ventures, and ROC Venture Group.
- Apr 15, 2022
$5M raised from Bayern Kapital, LifeArc Ventures, and ROC Venture Group.
For institutional investors. Book with your work email.
MC Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MC Sciences's valuation, stock price, and market status.
Is MC Sciences a public or private company?
MC Sciences is a private company.
What is the current stock price of MC Sciences?
MC Sciences is a private company, so its shares have no public market price. Caplight tracks MC Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MC Sciences worth (valuation)?
Valuation information for MC Sciences is not publicly available.
Can I buy MC Sciences stock?
MC Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MC Sciences's last funding round?
MC Sciences's most recent funding round was Series A on April 1, 2026.
Who are the main investors in MC Sciences?
Key investors in MC Sciences include ROC Venture Group, Canaan Partners, LifeArc Ventures, Bayern Kapital.
Will MC Sciences IPO soon?
No public IPO plans have been announced for MC Sciences.
How can I track MC Sciences secondary market activity?
Caplight tracks bids, offers, and trades in MC Sciences's shares on secondary markets.